Publisher
Springer International Publishing
Reference38 articles.
1. Bischoff H (1991) Wirkung von Acarbose auf diabetische Spätkomplikationen und Risikofaktoren – Neue tierexperimentelle Ergebnisse. Aktuelle Endokrinologie Stoffwechel 12:25–32
2. Bischoff H (1994) Pharmacology of α-glucosidase inhibition. Eur J Clin Invest 24(Suppl 3):3–10
3. Bischoff H, Puls W, Krause HP, Schutt H, Thomas G (1985) Pharmacological properties of the novel glucosidase inhibitors BAYM1099 (Miglitol) and BAY O 1248. Diabetes Res Clin Pract 8(Suppl 1):S53
4. Lembcke B, Lamberts R, Creutzfeldt W (1991) Lysosomal storage of glycogen as a sequel of α-glucosidase inhibition by the absorbed deoxynojirimycin derivative emiglitate (BAYo1248). A drug-induced pattern of hepatic glycogen storage mimicking Pompe’s disease (glycogenosis type II). Res Exp Med 191:389–404
5. Shainkin R, Birk Y (1970) α-Amylase inhibitors from wheat. Isolation and characterization. Biochim Biophys Acta 221:502–513